Drug/Insect/Latex News

Recent data from the Journal of Allergy and Clinical Immunology indicate that almost half of consumers in the U.S. and Canada falsely believe that the law requires the food industry to place precautionary allergen labeling on products.

NEW YORK — Symptoms alone are not enough reason to test a patient for Lyme disease, and not every patient with Lyme disease will present with target lesions, according to a presentation at the 2016 Infectious Diseases in Children Symposium.

Interviews with representatives from two dozen colleges showed most were not prepared to handle students with food allergies, according to study findings presented at the American College of Allergy, Asthma and Immunology Scientific Meeting.

While most surveyed non-nurse school staff correctly identified the protocol to treat severe allergic reactions among students, few felt confident in their ability to recognize symptoms or treat anaphylaxis, as stated by a study presented at the 2016 American College of Allergy, Asthma and Immunology Annual Scientific Meeting.

Many inpatient providers do not refer patients with penicillin allergy in their medical history to an allergy specialist, despite the benefit to the patient’s health, according to study findings presented at the American College of Allergy, Asthma and Immunology Scientific Meeting.

The pharmaceutical company kaléo announced the epinephrine auto-injector AUVI-Q will be available again for the treatment of life-threatening allergic reactions in the first quarter of 2017, and hopes to make it affordable to all patients.   

LAS VEGAS — A novel interleukin-13 inhibitor improved esophageal eosinophilic inflammation and endoscopic appearance in patients with eosinophilic esophagitis, according to results from the multicenter phase 2 HEROES study presented at ACG 2016.

Few parents of children with food allergies who self-report a current food allergy were actually found to have sensitivity to the reported allergen, according to study results published in the Annals of Allergy, Asthma and Immunology.

Second Genome has announced it is partnering with King’s College London to conduct microbiome profiling and analysis for a study in eczema and food allergies in young children.

The risk for developing egg or peanut allergy later in life was significantly lowered by introducing the allergenic food into infants’ diets early, according to recent study findings.